Akebia Therapeutics, Inc. (AKBA)

Last Three Months

19-Jan-24 -- 18-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Sell

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

26

0

7

+1

0

+2

0

+3

Two Year Chart

19-Apr-22 -- 18-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
01-Mar-24 5:47 PM View:	29-Feb-24 Sale ($73.58K)	Butler John P. CEO and President Director		Akebia Therapeutics, Inc. - AKBA	25% 1.89M to 2.36M	0	0	--	--	Show Txns Hide Txns

01-Mar-24 5:46 PM View:	29-Feb-24 Sale ($11.33K)	Burke Steven Keith SVP, Chief Medical Officer		Akebia Therapeutics, Inc. - AKBA	30% 533.49K to 695.84K	0	0	--	--	Show Txns Hide Txns

01-Mar-24 5:48 PM View:	29-Feb-24 Sale ($9.44K)	Hadas Nicole R. SVP, Chief Legal Officer		Akebia Therapeutics, Inc. - AKBA	26% 527.34K to 663.26K	0	0	--	--	Show Txns Hide Txns

01-Mar-24 5:49 PM View:	29-Feb-24 Sale ($13.68K)	Dahan Michel SVP, Chief Operating Officer		Akebia Therapeutics, Inc. - AKBA	23% 577.04K to 706.93K	0	0	--	--	Show Txns Hide Txns

02-Feb-24 4:10 PM View:	31-Jan-24 Grant 0	Snow Ellen SVP, CFO and Treasurer		Akebia Therapeutics, Inc. - AKBA	40% 370.0K to 519.3K	0	0	--	--	Show Txns Hide Txns

02-Feb-24 4:11 PM View:	31-Jan-24 Grant 0	Malabre Richard C Chief Accounting Officer		Akebia Therapeutics, Inc. - AKBA	100% 0 to 223.95K	0	0	--	--	Show Txns Hide Txns

02-Feb-24 4:11 PM View:	31-Jan-24 Grant 0	Grund Nicholas Chief Commercial Officer		Akebia Therapeutics, Inc. - AKBA	100% 0 to 303.3K	0	0	--	--	Show Txns Hide Txns